Impact of COVID-19 in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Enrolled in the DELIVER Trial is a research paper published in European Journal of Heart Failure (2023). On theSindex it has a DataRank of 0.691. It has been cited 16 times, with 16 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0.266
From 11 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 16 citers.
National Institutes of Health
Grant: 5R01HL140731-03
Machine learning for the automated identification and tracking of rare myocardial diseases
National Institutes of Health
Grant: 5R01HL127028-03
Transition from Risk Factors to Early HF: Prevalence, Pathogenesis, and Phenomics
National Institutes of Health
Grant: 5R01HL107577-06
Determinants, Trajectories, and Consequences of Abnormal Cardiac Mechanics
National Institutes of Health
Grant: 5R01HL149423-04
Precision Medicine for Dilated Cardiomyopathy—Novel Assessment of Cardiac Mechanics via Speckle Tracking Echocardiography to Identify Early Phenotypes
National Institutes of Health
Grant: 1U54HL160273-01
HeartShare DeCODE-HF: Data translation center to Combine Omics, Deep phenotyping, and Electronic health records for Heart Failure subtypes and treatment targets
AstraZeneca
AstraZeneca
FWCI
2.72
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals